SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan
NEOG 6.295+2.1%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kramer who wrote ()7/23/1999 1:34:00 AM
From: Kramer  Read Replies (1) of 441
 
I attended neog's open house today. I know that most of you here are in neog because of food safety and so am I but, and you have heard me many times before mention growth opportunities and improving margins for the BotB vaccine (which BTW IMHO were confirmed by the CC and what I heard today) but what would you think if neog's Vetoquinol product became a normal regime for vaccinations in every puppy in the country? Yes I mean dogs. I already knew that Vetoquinol was very useful in treating Feline leukemia and aids, but this was news too me. Now of course the product still needs to get approved for labeling for these uses before it can be marketed that way, and that will limit growth until that can happen. As with many other neog products, vetoquinol I understand also has a pretty nice margin too.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext